Pacific Biosciences of California, Inc. Cash and Cash Equivalents, Fair Value Disclosure
Pacific Biosciences of California, Inc. (PACB) had Cash and Cash Equivalents, Fair Value Disclosure of $61.00 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Fair Value Disclosures
us-gaap:CashAndCashEquivalentsFairValueDisclosure · last filed 2026-08-06
- 2026-06-30: Cash and Cash Equivalents, Fair Value Disclosure $61.00M.
- 2026-03-31: Cash and Cash Equivalents, Fair Value Disclosure $56.27M.
- 2025-12-31: Cash and Cash Equivalents, Fair Value Disclosure $63.71M.
- 2025-09-30: Cash and Cash Equivalents, Fair Value Disclosure $56.47M.
| Period end | Cash and Cash Equivalents, Fair Value Disclosure |
|---|---|
| 2026-06-30 | $61.00M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $56.27M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $63.71M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $56.47M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $54.80M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $58.51M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $55.37M 10-K · filed 2026-02-25 |
| 2024-09-30 | $77.98M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $99.53M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $76.65M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $179.91M 10-Q · filed 2024-11-12 |
| 2023-09-30 | $385.65M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $209.29M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $353.83M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $325.09M 10-K · filed 2024-02-28 |
| 2022-09-30 | $304.43M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $310.44M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $428.57M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $460.73M 10-K · filed 2023-02-28 |
| 2021-09-30 | $425.39M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $459.79M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $932.40M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $81.61M 10-K · filed 2022-02-28 |
| 2020-09-30 | $69.03M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $43.34M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $68.86M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $29.63M 10-K · filed 2021-02-26 |
| 2018-12-31 | $18.84M 10-K · filed 2020-02-28 |
| 2017-12-31 | $16.51M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |